Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Blast Crisis 1Anemia, Aplastic 1

Interventions

fludarabine phosphate 55Cyclophosphamide 49Peripheral Blood Stem Cell Transplantation 47Mycophenolic Acid 40Tacrolimus 38Whole-Body Irradiation 32Busulfan 27Cyclosporine 25Antilymphocyte Serum 25Methotrexate 21Filgrastim 21fludarabine 19Melphalan 19Radiotherapy 14Methylprednisolone 13Sirolimus 11Flow Cytometry 10Etoposide 10Alemtuzumab 10Cord Blood Stem Cell Transplantation 9Rituximab 8Psychiatric Rehabilitation 8Granulocyte Colony-Stimulating Factor 8Therapeutics 7Polymerase Chain Reaction 7thymoglobulin 6sargramostim 5Prednisone 5Ondansetron 4Immunologic Techniques 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myeloproliferative Disorders × CT-P10 × Plasma cell × Clear all
NCT02960646 2023-02-16

Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
11 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Blast Crisis, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡